DNLI vs ILMN · rev $3.6M vs rev $2.25B
Denali Therapeutics Inc (DNLI) versus Illumina Inc (ILMN) — a side-by-side from cached financials, not a winner call.
Denali Therapeutics Inc (DNLI) is a biotechnology company listed on US.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Latest reported DNLI revenue for 2026-06-30 was $3.6M. Net income was -$256.0M. DNLI currently screens at market cap $2.11B.
Latest reported ILMN revenue for 2026-06-28 was $2.25B. Net income was $340.0M. ILMN currently screens at market cap $15.84B.
DNLI currently screens at market cap $2.11B. ILMN currently screens at market cap $15.84B.
Not investment advice. Open the DNLI and ILMN stock pages for the full models.
Not investment advice.